Changyao Group(SZ:300391) Zhi Tong Cai Jing·2025-11-07 11:09Core Viewpoint - The company *ST长药 (300391.SZ) has received a notice from the China Securities Regulatory Commission (CSRC) regarding an investigation into suspected false reporting of financial data, which may lead to severe penalties and potential delisting from the Shenzhen Stock Exchange if found guilty [1] Summary by Relevant Sections - Investigation Details - The company was notified on November 7, 2025, about the investigation due to allegations of false financial reporting [1] - The CSRC's decision to initiate the investigation is based on relevant laws and regulations [1] - Potential Consequences - If the CSRC confirms the allegations and determines that they constitute a major violation under the revised Shenzhen Stock Exchange listing rules (2025), the company may face mandatory delisting [1]